Tech Company Financing Transactions

HTG Molecular Diagnostics Funding Round

Oxford Finance and Silicon Valley Bank participated in a $16 million funding round for HTG Molecular Diagnostics. The round was recorded on 9/2/2014.

Transaction Overview

Company Name
HTG Molecular Diagnostics
Announced On
9/2/2014
Transaction Type
Debt
Amount
$16,000,000
Round
Undisclosed
Investors

Oxford Finance (Christopher Herr)

Silicon Valley Bank (Michael White)

Proceeds Purpose
Together with the capital raised through recent equity offerings, the debt facility with SVB/Oxford provides HTG the funding needed to pursue several operating initiatives, including key research and development (R&D) programs and strategic sales and marketing expansion.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3430 East Global Loop
Tucson, AZ 85706
USA
Phone
(877) 289-2615
Website
www.htgmolecular.com
Email Address
[email protected]
Overview
Headquartered in Tucson, Arizona, HTG Molecular Diagnostics' mission is to empower precision medicine at the local level.
Profile
HTG Molecular Diagnostics LinkedIn Company Profile
Social Media
HTG Molecular Diagnostics Company Twitter Account
Company News
HTG Molecular Diagnostics News
Facebook
HTG Molecular Diagnostics on Facebook
YouTube
HTG Molecular Diagnostics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Timothy Johnson
  Timothy Johnson LinkedIn Profile  Timothy Johnson Twitter Account  Timothy Johnson News  Timothy Johnson on Facebook
Chief Executive Officer
John Lubniewski
  John Lubniewski LinkedIn Profile  John Lubniewski Twitter Account  John Lubniewski News  John Lubniewski on Facebook
VP - Finance
Shaun McMeans
  Shaun McMeans LinkedIn Profile  Shaun McMeans Twitter Account  Shaun McMeans News  Shaun McMeans on Facebook
VP - Regulatory Affairs
Sam Rua
  Sam Rua LinkedIn Profile  Sam Rua Twitter Account  Sam Rua News  Sam Rua on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/2/2014: Thar Pharmaceuticals venture capital transaction
Next: 9/2/2014: Clearside Biomedical venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.